The Jeonnam Bio Institute is transferring research results related to blood sugar control using rice-based syrup to a local agricultural company, Enzyme Farm, to develop and commercialize health supplements.
The institute announced that it has signed a technology transfer agreement with Enzyme Farm for the development of health supplements aimed at blood sugar control and improvement.
This agreement was initiated to apply research findings confirming the blood sugar control efficacy of syrup production processes in the industry.
The technology being transferred pertains to a patented process for developing blood sugar control syrup.
Both organizations plan to utilize this technology to enhance the competitiveness of rice-based syrup and jam products, ensuring that research and development results lead to actual product production and commercialization.
Enzyme Farm is a specialized agricultural company that focuses on exploring effective components in rice-based syrup and jams, as well as their research, development, production, and commercialization.
With this technology transfer, the company aims to integrate research findings into existing products and develop new offerings targeting consumers interested in blood sugar management.
However, it is important to note that this agreement is in the stage of product development based on research results, and it does not imply that the syrup has been recognized as a health supplement or that its blood sugar improvement effects have been proven in humans.
Kim Joo-ho, CEO of Enzyme Farm, stated, "We will apply the transferred patented technology for blood sugar control syrup development to our product development and actively pursue exports of K-syrup and jams."
Recently, consumer interest in reducing sugar intake and managing blood sugar levels has been rising, leading to an expansion in the development of related products.
According to data presented by the Jeonnam Bio Institute, the domestic blood sugar-related market size increased from 33.7 billion won in 2020 to 58.5 billion won in 2023, marking an approximate 73% growth.
As a result, efforts are underway to combine functional research and manufacturing process technology with traditional syrup products to explore new markets.
In particular, if the commercialization of rice-based syrup expands, it is expected to enhance the processing demand and added value of local agricultural products.
Yang Eun-joo, head of the AI Convergence Support Office at the Jeonnam Bio Institute, expressed, "We aim to contribute to the revitalization of the local economy through the industrialization of rice-based syrup and jams," emphasizing the commitment to ongoing collaboration with Enzyme Farm.
Meanwhile, this technology transfer is part of a collaborative project to connect the research achievements of the Jeonnam Bio Institute with product development and commercialization by local companies. Future verification of product functionality, related approvals, and commercialization efforts are expected to be key challenges for actual market entry.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.